AVEO - AVEO Pharmaceuticals' (AVEO) CEO Michael Bailey on Q1 2022 Results - Earnings Call Transcript
AVEO Pharmaceuticals, Inc. (AVEO) Q1 2022 Earnings Conference Call May 05, 2022 8:00 AM ET Company Participants Hans Vitzthum – LifeSci Advisors Michael Bailey – President and Chief Executive Officer Mike Ferraresso – Chief Commercial Officer Erick Lucera – Chief Financial Officer Jeb Ledell – Chief Operating Officer Conference Call Participants Colleen Kusy – Baird Andrew Berens – SVB Securities Soumit Roy – Jones Research Swayampakula Ramakanth – H.C. Wainwright Presentation Operator Good morning, and welcome to AVEO Oncology First Quarter 2022 Financial Results Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, today’s conference is being recorded. I will now turn the call over to Hans Vitzthum of LifeSci Advisors. Please go ahead, sir. Hans Vitzthum Good afternoon and thank you all for joining us on today’s call to discuss AVEO’s first quarter
For further details see:
AVEO Pharmaceuticals' (AVEO) CEO Michael Bailey on Q1 2022 Results - Earnings Call Transcript